| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |